Jump to content

Carbidopa/levodopa

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Arcadian (talk | contribs) at 15:37, 5 November 2008 (infobox). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Carbidopa/levodopa
Combination of
AgonistCarbidopa
Enzyme inhibitorLevodopa
Clinical data
ATC code
Identifiers
CompTox Dashboard (EPA)

The combination of carbidopa and levodopa is used to treat Parkinson's disease[1] and Dopa-Responsive Dystonia (DRD). The generic name under the British Approved Name system is Co-careldopa.

It is sold under several brand names, including Sinemet;, Parcopa, and Atamet.

References

  1. ^ Nyholm D (2006). "Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease". Expert review of neurotherapeutics. 6 (10): 1403–11. doi:10.1586/14737175.6.10.1403. PMID 17078781. {{cite journal}}: Unknown parameter |month= ignored (help)
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Carbidopa/levodopa&oldid=249853669"